跳至主要内容
临床试验/NCT00198562
NCT00198562Unknown4 期

Hypertension Control Based on Home Systolic Pressure Study (HOSP Study)

Ministry of Health, Labour and Welfare, Japan1 个研究点 分布在 1 个国家目标入组 2,600 人开始时间: 2000年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
2,600
试验地点
1
主要终点
Combined cardiovascular events

研究概览

简要总结

The aim of this trial is to study the effects of antihypertensive therapy based on home systolic blood pressure (BP) with different target levels using two classes of drugs.

The HOSP study is a multicenter, prospective, randomized, open, blinded endpoint study. The study subjects are 40-79 years old hypertensive patients. After a 4 weeks of baseline period, subjects are randomly assigned to (1) modest control group (morning home BP <140 mmHg) or (2) strict control group (morning home BP <130 mmHg), and to (a) amlodipine group or (b) losartan group. Additional antihypertensive drugs can be used if home BP is not controlled. Home BP is measured in the early morning and late evening. The participants will be followed up for 5 years.

详细描述

The aim of this trial is to study the effects of antihypertensive therapy based on home systolic blood pressure (BP) with different target levels using two classes of drugs.

The HOSP study is a multicenter, prospective, randomized, open, blinded endpoint study. Inclusion criteria are 40-79 years old treated or untreated hypertensive patients without serious medical conditions. After a 4 weeks of baseline period, subjects are randomly assigned to (1) modest control group (target morning home BP <140 mmHg) or (2) strict control group (morning home BP <130 mmHg), and to (a) amlodipine group (2.5-5 mg od) or (b) losartan group (25-50 mg od). Additional antihypertensive drugs (diuretics, beta-blockers and alpha-blockers) can be used if home BP is not controlled. Home BP is measured in the early morning and late evening. Primary end point is combined cardiovascular events.The participants will be followed up for 5 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of hypertension

排除标准

  • Severe hypertension (treated with 3 or more antihypertensive drugs)
  • Unable to change antihypertensive drugs to a calcium antagonist or an angiotensin antagonist
  • Serious medical conditions
  • Women who may become to be pregnant

研究组 & 干预措施

1

Active Comparator

target morning home blood pressure (below 130 mmHg vs 130-139 mmHg)

干预措施: Amlodipine, Losartan (Drug)

2

Active Comparator

antihypertensive drug (amlodipine vs losartan)

干预措施: Amlodipine, Losartan (Drug)

结局指标

主要结局

Combined cardiovascular events

时间窗: 5 years

次要结局

  • Total mortality(5 years)
  • Cardiovascular mortality(5 years)
  • Myocardial infarction and new-onset angina(5 years)
  • Stroke and transient ischemic attack(5 years)
  • Renal failure(5 years)
  • Aortic and peripheral artery diseases(5 years)
  • Left ventricular mass and function(5 years)
  • Urinary albumin and renal function(5 years)

研究者

发起方
Ministry of Health, Labour and Welfare, Japan
申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验